What is Ligand Pharmaceuticals's total revenue?

Ligand Pharmaceuticals (LGND) reported total revenue of $51.72M in Q1 2026.

How has Ligand Pharmaceuticals's total revenue changed year-over-year?

Ligand Pharmaceuticals's total revenue increased by 14.1% year-over-year, from $45.33M to $51.72M.

What is the long-term trend for Ligand Pharmaceuticals's total revenue?

Over 4 years (2021 to 2025), Ligand Pharmaceuticals's total revenue has grown at a 2.6% compound annual growth rate (CAGR), from $241.54M to $268.09M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ligand Pharmaceuticals LGND Total Revenue

Total Revenue at other companies

Royalty PharmaRPRX

$630.58M+11.0%

RevvityRVTY

$711.12M+7.0%

BridgeBio PharmaBBIO

$194.52M+66.8%

Ionis PharmaceuticalsIONS

$246.09M+87.0%

LQD

Liquidia CorporationLQDA

——

Mirum Pharmaceuticals, Inc.MIRM

——

Segments

By product

See full

Filspari$11.32M+114%

Captisol$8.65M—

Kyprolis$6.74M—

Qarziba$6.3M+15.7%

Evomela$5.94M-31.5%

Rylaze$3.81M+3.7%

By segment

See full

Development and Licensing of Biopharmaceutical Assets$51.72M+14.1%

Other financials

Income statement

See full

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.51B+96.7%

Enterprise value$5.4B+95.4%

P/E35.9×—

P/S20.1×+4.6×

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's total revenue?: Ligand Pharmaceuticals (LGND) reported total revenue of $51.72M in Q1 2026.
How has Ligand Pharmaceuticals's total revenue changed year-over-year?: Ligand Pharmaceuticals's total revenue increased by 14.1% year-over-year, from $45.33M to $51.72M.
What is the long-term trend for Ligand Pharmaceuticals's total revenue?: Over 4 years (2021 to 2025), Ligand Pharmaceuticals's total revenue has grown at a 2.6% compound annual growth rate (CAGR), from $241.54M to $268.09M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.